Skip to main content
. 2017 Feb 6;24(1):346–357. doi: 10.1080/10717544.2016.1253798

Figure 4:

Figure 4:

(A) Plasma level of DTX in rats after intravenous administration of L-DTX, free drug and Taxotere®. (B) Concentration of DTX in brain after intravenous administration of nanoliposomal formulation containing DTX (L-DTX), marketed formulation (Taxotere®) and free drug to rats at a dose of 10 mg/kg of DTX. Note: Data show mean ± standard deviation (n = 3).